USPTO serial 99820805
Reviewed by CopyMark Law Group
Status 638 means your application has been assigned to a USPTO examining attorney who is reviewing it against federal law and existing marks. The first office action or approval usually follows within a few months. Monitor TSDR for the examiner's first action. No filing is required until an office action or other requirement is issued.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Janet M. Garetto
Janet M. Garetto Nixon Peabody LLP70 W. Madison Street, Suite 5200Chicago, IL 60602United States| Class | Description | Status | First use |
|---|---|---|---|
| 040 | Custom manufacturing of dietary supplements, nutritional supplements, and food additives for others; custom manufacturing of dietary and nutritional supplements featuring biotechnology to enhance the delivery, release, and absorption of nutrients and bioactive compounds; custom processing and formulation of bioactive materials for others | ACTIVE | — |
| 042 | Research and development of new products for others in the fields of dietary supplements and nutritional supplements; custom formulation of dietary and nutritional supplements for others; product development consultation featuring the design of advanced delivery systems and bioavailability enhancement technologies; scientific research and development in the field of pharmacokinetics and nutrient delivery | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 14, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 31, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 13, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 13, 2026 | NWAP | NEW APPLICATION ENTERED | — |